schizandrin b has been researched along with tert-butylhydroperoxide in 2 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (tert-butylhydroperoxide) | Trials (tert-butylhydroperoxide) | Recent Studies (post-2010) (tert-butylhydroperoxide) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 2,272 | 3 | 575 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, KM; Lam, BY | 1 |
| Chen, Y; Deng, W; Ding, M; Gao, S; Gao, Y; He, G; Hu, Z; Li, T; Shu, P; Wang, F | 1 |
2 other study(ies) available for schizandrin b and tert-butylhydroperoxide
| Article | Year |
|---|---|
Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain.
Topics: Animals; Antioxidants; Brain; Cyclooctanes; Glutathione; Lignans; Mice; Molecular Structure; Oxidative Stress; Polycyclic Compounds; Protective Agents; tert-Butylhydroperoxide; Time Factors | 2002 |
Schisandrin B protects human keratinocyte-derived HaCaT cells from tert-butyl hydroperoxide-induced oxidative damage through activating the Nrf2 signaling pathway.
Topics: Antioxidants; Cell Death; Cell Line; Cyclooctanes; Humans; Keratinocytes; Lignans; Mitochondria; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Polycyclic Compounds; Protective Agents; Reactive Oxygen Species; Signal Transduction; tert-Butylhydroperoxide | 2018 |